drugset / Trial / NCT00819468
Pharmacokinetics (PK) of 20 mg Teduglutide in Participants With Moderately Impaired Hepatic Function Compared to Healthy Participants
Non-randomizedParallel-groupOpen-labelOther
Summary
This is a study to compare the pharmacokinetic profile of teduglutide in healthy participants with normal hepatic function with participants who have moderate hepatic impairment.
Timeline
- Start
- 2007-07-26
- Primary completion
- 2007-08-23
- Completion
- 2007-08-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Teduglutide | Peptide | 20 mg | Subcutaneous |
Indications
No indication recorded.